Get the Stockscreener App
67.42
0.69%
0.46
Pre-market:
63.50
-3.92
-5.81%
Livanova Plc stock is traded at $67.42, with a volume of 1.08M.
It is up +0.69% in the last 24 hours and up +8.55% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$66.96
Open:
$66.82
24h Volume:
1.08M
Relative Volume:
1.76
Market Cap:
$3.68B
Revenue:
$1.35B
Net Income/Loss:
$-217.48M
P/E Ratio:
-16.81
EPS:
-4.0106
Net Cash Flow:
$191.43M
1W Performance:
+1.49%
1M Performance:
+8.55%
6M Performance:
+26.56%
1Y Performance:
+42.81%
1-Day Range:
$66.72
$68.00
1-Week Range:
$62.91
$68.00
52-Week Range:
$32.48
$68.00
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
67.42 | 3.66B | 1.35B | -217.48M | 191.43M | -4.0106 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
LivaNova stock hits 52-week high at $68.00 By Investing.com - Investing.com South Africa
LivaNova (NASDAQ:LIVN) Hits New 52-Week HighHere's Why - MarketBeat
LivaNova stock hits 52-week high at $68.00 - Investing.com
Cardiovascular Devices Market Booming Rapidly from 2026 to 2033 - openPR.com
LivaNova (LIVN) to Release Quarterly Earnings on Wednesday - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Sees Large Growth in Short Interest - MarketBeat
LivaNova (NASDAQ:LIVN) Procedure Trends Intersect With Nasdaq Today Moves - Kalkine Media
What’s the fair value of LivaNova PLC stock2025 Biggest Moves & Verified Momentum Stock Watchlist - mfd.ru
(LIVN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Will LivaNova PLC stock remain a Wall Street favoriteJuly 2025 Patterns & Expert Approved Momentum Ideas - mfd.ru
LSV Asset Management Raises Stake in LivaNova PLC $LIVN - MarketBeat
Is LivaNova PLC subject to activist investor interest2025 Historical Comparison & Fast Entry High Yield Tips - mfd.ru
What margin trends mean for LivaNova PLC stockWeekly Trade Summary & AI Based Buy/Sell Signal Reports - mfd.ru
Risk Analysis: Can DECK beat the S P 500Market Activity Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Can LivaNova PLC outperform in the next rallyJuly 2025 Short Interest & Smart Money Movement Tracker - mfd.ru
Allianz Asset Management GmbH Makes New $7.69 Million Investment in LivaNova PLC $LIVN - MarketBeat
LivaNova to present at JP Morgan Healthcare Conference in January - MSN
New York State Common Retirement Fund Acquires 93,267 Shares of LivaNova PLC $LIVN - MarketBeat
Bioelectric Medicine Market is expected to reach US$ 235.55 - openPR.com
LivaNova PLC (LIVN) Stock Analysis: Promising 9.35% Upside as Healthcare Innovator Surges - DirectorsTalk Interviews
Responsive Playbooks and the LIVN Inflection - Stock Traders Daily
A Look At LivaNova (LIVN) Valuation After KeyBanc Upgrade And Renewed Medtech Optimism - Sahm
LivaNova Stock Checks Its Pulse: Can LIVN’s Recent Slide Set Up A Recovery Rally? - AD HOC NEWS
LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What LivaNova (LIVN)'s KeyBanc Upgrade and Medtech Reassessment Means For Shareholders - simplywall.st
LivaNova stock reaches 52-week high at $65.95 By Investing.com - Investing.com Australia
LivaNova (LIVN) Upgraded to Overweight by KeyBanc - Finviz
What are KeyBanc’s Top MedTech Picks By Investing.com - Investing.com Nigeria
What are KeyBanc’s Top MedTech Picks - Investing.com
LivaNova (NASDAQ:LIVN) Sets New 1-Year HighHere's What Happened - MarketBeat
LivaNova stock reaches 52-week high at $65.95 - Investing.com
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up - Yahoo Finance
From Humanoid Robots to AI Seating: VivaNova Debuts "Active Health" Tech at imm cologne 2026 - GlobeNewswire Inc.
Understanding the Setup: (LIVN) and Scalable Risk - Stock Traders Daily
Autotransfusion System Market is expected to reach US$ 1,094.30 - openPR.com
Emerald Mutual Fund Advisers Trust Purchases 26,202 Shares of LivaNova PLC $LIVN - MarketBeat
Cardiac Pacemaker Market Covering Prime Factors - openPR.com
SG Americas Securities LLC Reduces Stake in LivaNova PLC $LIVN - MarketBeat
Assessing LivaNova (LIVN) Valuation As Shares Track Recent Momentum And Ongoing Losses - simplywall.st
These 4 Measures Indicate That LivaNova (NASDAQ:LIVN) Is Using Debt Safely - 富途资讯
Extracorporeal Membrane Oxygenation (ECMO) Machines Market - openPR.com
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - marketscreener.com
Should I buy LivaNova PLC (LIA) stock before earnings seasonEarnings Volatility Patterns & Small Investment Portfolio - bollywoodhelpline.com
Medical Implants Market Is Booming So Rapidly Growth by 2033 |Biotronik, Inc., Livanova Plc, NuVasive - openPR.com
Are Options Traders Betting on a Big Move in LivaNova Stock? - MSN
What risks investors should watch in LivaNova PLC stockEconomic Indicators Overview & Top Analyst Picks Available for Free - bollywoodhelpline.com
Wall Street Recap: Can LivaNova PLC maintain sales growth2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn
LivaNova (NASDAQ:LIVN) Stock Price Crosses Above 50 Day Moving AverageTime to Sell? - MarketBeat
Aug Chart Watch: Whats the fair value of LivaNova PLC stock2025 Growth vs Value & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Deep Brain Stimulation Devices Market Valuation Set to Achieve - openPR.com
LivaNova Announces Chief Legal Officer Resignation and Succession - The Globe and Mail
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):